Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Degenerations”

2,105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,105 results

Testing effectiveness (Phase 2)UnknownNCT02709876
What this trial is testing

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Stem Cells Arabia 50
Testing effectiveness (Phase 2)UnknownNCT01680510
What this trial is testing

The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil

Who this might be right for
Retinitis Pigmentosa
Sheba Medical Center 100
Testing effectiveness (Phase 2)WithdrawnNCT02122159
What this trial is testing

Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration

Who this might be right for
Myopic Macular Degeneration
University of California, Los Angeles
Not applicableStudy completedNCT03438669
What this trial is testing

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients

Who this might be right for
Macular Degeneration
Dr. med. Katja Hatz 53
Large-scale testing (Phase 3)Study completedNCT00590694
What this trial is testing

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

Who this might be right for
Age-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular Degeneration+1 more
Pacific Eye Associates 15
Post-approval studies (Phase 4)Study completedNCT00494494
What this trial is testing

Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery

Who this might be right for
Cystoid Macular Edema
University of North Carolina, Chapel Hill 82
Early research (Phase 1)Study completedNCT00791570
What this trial is testing

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Who this might be right for
Neovascular MaculopathyAge Related Macular Degeneration
Osaka University 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607561
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
wetAMDAge Related Macular Degeneration
SCAI Therapeutics 50
Not applicableLooking for participantsNCT07004361
What this trial is testing

Ethical Issues of Using Gene Therapy in the Treatment of AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Nantes University Hospital 30
Post-approval studies (Phase 4)UnknownNCT03468296
What this trial is testing

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Tennessee Retina 22
Testing effectiveness (Phase 2)Study completedNCT03780257
What this trial is testing

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
ProQR Therapeutics 20
Not applicableStudy completedNCT02028351
What this trial is testing

Vision Measured by the Vimetrics CVA Compared With Chart Testing Under Similar Luminance and Contrast Conditions

Who this might be right for
Refractive ErrorCataractMaculopathy
Sinclair Technologies, LLC 150
Post-approval studies (Phase 4)UnknownNCT02788877
What this trial is testing

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)

Who this might be right for
Macular Edema, Diabetic
Pusan National University Hospital 48
Large-scale testing (Phase 3)Ended earlyNCT00406744
What this trial is testing

Efficacy of Retreatments With Intravitreal Bevacizumab

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Asociación para Evitar la Ceguera en México 20
Not applicableStudy completedNCT02310295
What this trial is testing

Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
University of Sao Paulo 45
Testing effectiveness (Phase 2)WithdrawnNCT04358471
What this trial is testing

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyGene Therapy+1 more
Hemera Biosciences
Large-scale testing (Phase 3)Ended earlyNCT01786395
What this trial is testing

Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
R-Tech Ueno, Ltd. 202
Not applicableStudy completedNCT03470103
What this trial is testing

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

Who this might be right for
Macular Degeneration
Bayer 643
Not applicableActive Not RecruitingNCT04645212
What this trial is testing

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 23
Not applicableStudy completedNCT03314207
What this trial is testing

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

Who this might be right for
X-Linked Retinitis Pigmentosa
Beacon Therapeutics 14
Next Page